On January 22, 2016, the FDA released a draft of its recommendations for managing postmarket cybersecurity vulnerabilities for marketed medical devices.

The draft outlines the steps that medical devices manufacturers should take to continually address cybersecurity risks in order to better protect the public health. the document address to premarket and postmarket considerations, cybersecurity risk management, remediating and reporting cybersecurity vulnerabilities, etc. The draft contains nonbinding recommendations, official guidance document was not published yet.

  Read More-FDA